These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 17420989

  • 1. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI, Fisher M.
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [Abstract] [Full Text] [Related]

  • 2. A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
    Savitz SI.
    Exp Neurol; 2007 May; 205(1):20-5. PubMed ID: 17408618
    [Abstract] [Full Text] [Related]

  • 3. Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke.
    Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL, Finklestein SP, Pangalos MN, Poole M, Stiles GL, Ruffolo RR, Walsh FL.
    J Cereb Blood Flow Metab; 2008 Jan; 28(1):217-9. PubMed ID: 17579658
    [Abstract] [Full Text] [Related]

  • 4. NXY-059: review of neuroprotective potential for acute stroke.
    Fong JJ, Rhoney DH.
    Ann Pharmacother; 2006 Mar; 40(3):461-71. PubMed ID: 16507608
    [Abstract] [Full Text] [Related]

  • 5. [Past, present and future of neuroprotection].
    Mracek J.
    Cas Lek Cesk; 2010 Mar; 149(12):586-90. PubMed ID: 21387585
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotection in acute ischemic stroke.
    De Keyser J, Uyttenboogaart M, Koch MW, Elting JW, Sulter G, Vroomen PC, Luijckx GJ.
    Acta Neurol Belg; 2005 Sep; 105(3):144-8. PubMed ID: 16255152
    [Abstract] [Full Text] [Related]

  • 7. 1,026 experimental treatments in acute stroke.
    O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW.
    Ann Neurol; 2006 Mar; 59(3):467-77. PubMed ID: 16453316
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic strategies for the treatment of stroke.
    Green AR, Shuaib A.
    Drug Discov Today; 2006 Aug; 11(15-16):681-93. PubMed ID: 16846795
    [Abstract] [Full Text] [Related]

  • 9. Perspectives on neuroprotective stroke therapy.
    Schäbitz WR, Fisher M.
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1271-6. PubMed ID: 17073800
    [Abstract] [Full Text] [Related]

  • 10. Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices.
    Savitz SI, Benatar M, Saver JL, Fisher M.
    Cerebrovasc Dis; 2008 Dec; 26(2):156-62. PubMed ID: 18560219
    [Abstract] [Full Text] [Related]

  • 11. New perspectives on developing acute stroke therapy.
    Fisher M, Ratan R.
    Ann Neurol; 2003 Jan; 53(1):10-20. PubMed ID: 12509843
    [Abstract] [Full Text] [Related]

  • 12. Recent advances in pharmacologic neuroprotection.
    Mantz J, Degos V, Laigle C.
    Eur J Anaesthesiol; 2010 Jan; 27(1):6-10. PubMed ID: 19617840
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotection in cerebral infarction: the opportunity of new studies.
    Pérez de la Ossa N, Dávalos A.
    Cerebrovasc Dis; 2007 Jan; 24 Suppl 1():153-6. PubMed ID: 17971651
    [Abstract] [Full Text] [Related]

  • 14. Treatment with statins in the acute phase of ischemic stroke.
    Montaner J.
    Expert Rev Neurother; 2005 Mar; 5(2):211-21. PubMed ID: 15853491
    [Abstract] [Full Text] [Related]

  • 15. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.
    Durukan A, Tatlisumak T.
    Pharmacol Biochem Behav; 2007 May; 87(1):179-97. PubMed ID: 17521716
    [Abstract] [Full Text] [Related]

  • 16. The past and future of neuroprotection in cerebral ischaemic stroke.
    Shuaib A, Hussain MS.
    Eur Neurol; 2008 May; 59(1-2):4-14. PubMed ID: 17917451
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New approaches to neuroprotective drug development.
    Fisher M.
    Stroke; 2011 Jan; 42(1 Suppl):S24-7. PubMed ID: 21164111
    [Abstract] [Full Text] [Related]

  • 19. Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.
    Philip M, Benatar M, Fisher M, Savitz SI.
    Stroke; 2009 Feb; 40(2):577-81. PubMed ID: 19074479
    [Abstract] [Full Text] [Related]

  • 20. Treating acute ischemic stroke.
    Fisher M, Bastan B.
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):626-32. PubMed ID: 18729014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.